Chi Fu Chen

US Patent:

20080244519, Oct 2, 2008

Filed:

Mar 30, 2007

Appl. No.:

11/694294

Inventors:

Michael Anthony Sciacqua - North Bend WA, US
Suma SaganeGowda - Woodinville WA, US
Tri Minh Hua - Seattle WA, US
Magdi Morsi - Bellevue WA, US
Yevgeniya Ross - Redmond WA, US
Stephen Edward Kreyenbuhl - Bothell WA, US
Jee Fung Pang - Woodinville WA, US
Chi F. Chen - Bellevue WA, US

Assignee:

MICROSOFT CORPORATION - Redmond WA

International Classification:

G06F 9/44

US Classification:

717120, 715781, 717168

Abstract:

A method of identifying, correcting and displaying application website and device compatibility issues is disclosed. An agent framework is started that host compatibility agents. The compatibility agents are used to analyze an operating system user such as a device, an application or an update. The results of the compatibility agents are communicated to a database and the results of the compatibility agents are displayed using a user interface.

US Patent:

56700571, Sep 23, 1997

Filed:

Apr 28, 1995

Appl. No.:

8/434302

Inventors:

Chi Chen - Hawthorn Woods IL
Paul Emerson - St. Louis Park MN
Prakash Keshaviah - Plymouth MN

Assignee:

Baxter International Inc. - Deerfield IL

International Classification:

A61M 128

US Classification:

210739

Abstract:

There is disclosed a method and apparatus for automatically conducting peritoneal equilibration testing. The method involves removing a sample of overnight dwell fluid from a patient in an amount sufficient to determine the concentration of a metabolite in the drain fluid. The concentration of the metabolite in the sample is then detected and the overnight dwell fluid is drained and weighed. A known weight of dialysate fluid is instilled into a patient and thereafter there are periodically withdrawn samples of the dialysate fluid and the concentration of metabolite in each sample is determined. The ratio of metabolite concentration of each of the periodically drawn samples to metabolite concentration for the overnight dwell fluid is determined. The patient is then drained after a predetermined dwell time and the volume of drained dialysate is determined. The mass transfer area coefficient of the patient's peritoneal membrane is then obtained as a function of the measured variables.

US Patent:

59250119, Jul 20, 1999

Filed:

Oct 10, 1995

Appl. No.:

8/520805

Inventors:

Dirk Faict - Assenede, BE
Chi J. Chen - Hawthorn Woods IL
Francesco Peluso - Heverlee, BE
Robert Warren Childers - New Port Richie FL
Patrick Balteau - Jambes, BE
Vital Eerlingen - Leuven, BE
Paul Frederick Emerson - St. Louis Park MN
Lisa Colleran - Arlington Heights IL

Assignee:

Baxter International Inc. - Deerfield IL

International Classification:

A61M 100

US Classification:

604 29

Abstract:

A system and a method are provided for admixing solutions. The system includes containers separately accessible by one or more pumps for mixture of the solutions in a container immediately before administration to a peritoneal cavity of a patient. Alternatively, the system and method allow for direct administration of the mixed solution to the peritoneal cavity of a patient without intermediate mixing thereof. The solutions may be mixed in predetermined ratios as input to the system prior to delivery.

US Patent:

59655330, Oct 12, 1999

Filed:

May 23, 1997

Appl. No.:

8/862480

Inventors:

Chi J. Chen - Hawthorn Woods IL
Ty R. Shockley - Highland Park IL
Miles G. Johnston - Pickering, Ontario, CA

Assignee:

Baxter International Inc. - Deerfield IL

International Classification:

A61K 3800
C07K 500
C07K 700
A01N 5908

US Classification:

514 12

Abstract:

The present invention provides a peritoneal dialysis solution that contains atrial natriuretic peptide (ANP), a derivative of ANP, an analogue of ANP, a substance that binds ANP to clearance receptors or a substance that promotes ANP synthesis, which results in an increased net ultrafiltration and increased sodium clearance experienced in peritoneal dialysis patients.